IDEXX LABORATORIES INC /DE Derivative Liability, Fair Value, Amount Not Offset Against Collateral
IDEXX LABORATORIES INC /DE (IDXX) had Derivative Liability, Fair Value, Amount Not Offset Against Collateral of -$2.11 million as of 2015-06-30, per its 10-Q filed 2015-07-30.
Discontinued › Notes › Offsetting › Derivative Liability, Subject to Master Netting Arrangement, after Offset and Deduction › Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral
us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral · last filed 2015-07-30
- 2015-06-30: Derivative Liability, Fair Value, Amount Not Offset Against Collateral -$2.11M.
- 2014-12-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral -$1.32M.
| Period end | Derivative Liability, Fair Value, Amount Not Offset Against Collateral |
|---|---|
| 2015-06-30 | -$2.11M 10-Q · filed 2015-07-30 |
| 2014-12-31 | -$1.32M 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |